As of 2025-09-18, the Relative Valuation of Fate Therapeutics Inc (FATE) is (22.16) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.95 USD, the upside of Fate Therapeutics Inc based on Relative Valuation is -2432.6%.
The range of the Relative Valuation is (21.27) - (23.05) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 14.3x - 15.5x | 14.9x |
| Forward P/E multiples | 14.2x - 15.6x | 14.9x |
| Fair Price | (21.27) - (23.05) | (22.16) |
| Upside | -2338.7% - -2526.5% | -2432.6% |
| Date | P/E |
| 2025-09-17 | -0.66 |
| 2025-09-16 | -0.64 |
| 2025-09-15 | -0.64 |
| 2025-09-12 | -0.65 |
| 2025-09-11 | -0.69 |
| 2025-09-10 | -0.67 |
| 2025-09-09 | -0.66 |
| 2025-09-08 | -0.65 |
| 2025-09-05 | -0.68 |
| 2025-09-04 | -0.65 |
| 2025-09-03 | -0.67 |
| 2025-09-02 | -0.69 |
| 2025-08-29 | -0.70 |
| 2025-08-28 | -0.73 |
| 2025-08-27 | -0.75 |
| 2025-08-26 | -0.75 |
| 2025-08-25 | -0.73 |
| 2025-08-22 | -0.77 |
| 2025-08-21 | -0.75 |
| 2025-08-20 | -0.76 |
| 2025-08-19 | -0.77 |
| 2025-08-18 | -0.81 |
| 2025-08-15 | -0.73 |
| 2025-08-14 | -0.72 |
| 2025-08-13 | -0.76 |
| 2025-08-12 | -0.63 |
| 2025-08-11 | -0.63 |
| 2025-08-08 | -0.62 |
| 2025-08-07 | -0.66 |
| 2025-08-06 | -0.70 |
| 2025-08-05 | -0.73 |
| 2025-08-04 | -0.71 |
| 2025-08-01 | -0.72 |
| 2025-07-31 | -0.74 |
| 2025-07-30 | -0.77 |
| 2025-07-29 | -0.79 |
| 2025-07-28 | -0.87 |
| 2025-07-25 | -0.83 |
| 2025-07-24 | -0.84 |
| 2025-07-23 | -0.86 |
| 2025-07-22 | -0.83 |
| 2025-07-21 | -0.77 |
| 2025-07-18 | -0.76 |
| 2025-07-17 | -0.77 |
| 2025-07-16 | -0.76 |
| 2025-07-15 | -0.76 |
| 2025-07-14 | -0.77 |
| 2025-07-11 | -0.77 |
| 2025-07-10 | -0.78 |
| 2025-07-09 | -0.77 |